Whole versus partial prostate radiation boost
Part of Cancer, Kidney & urinary clinical trials.
This trial compares giving radiation to the entire prostate gland versus just the main tumor area, in men with prostate cancer. It aims to see if a more targeted approach works as well, with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 19 years old.
- You have been diagnosed with prostate adenocarcinoma and your doctor has recommended a type of radiation called SBRT to the prostate.
- Your prostate is less than 100 cc in volume before starting hormone therapy.
- Your MRI shows a suspicious lesion rated PI-RADS 4 or 5.
- Your urinary symptom score (IPSS/AUA) is less than 16.
- You have not had prior treatment for prostate cancer, no other cancer in the last 5 years, and no history of anal, rectal, or invasive bladder cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of giving a radiation boost (brachytherapy) to the prostate for men with localized prostate cancer. One method targets only the visible tumor, while the other treats the whole gland, and the study aims to see if the focal approach works as well with fewer side effects.
This trial studies whether adding a stronger “boost” dose of targeted radiation (SBRT) can better control higher-risk prostate cancer. It may help by increasing radiation coverage to the prostate while trying to limit treatment to surrounding areas.
This trial tests whether giving higher radiation doses to the prostate and pelvic lymph nodes is more effective than treating only the prostate. You may benefit if your prostate cancer has spread to nearby lymph nodes but not to bones or other organs, and you are getting hormone therapy.
This trial tests a newer, more precise radiation treatment that gives a higher dose to the main tumor while keeping radiation to the rest of the prostate the same. It is for men with intermediate- or high-risk prostate cancer who haven't had prior prostate radiation or removal.
This trial tests a special type of radiation therapy (SBRT) that delivers a higher dose directly to the main tumor in your prostate, guided by a PSMA PET scan. It aims to improve cancer control while limiting side effects.
This study tests a new radiation treatment approach that uses MRI imaging to target specific tumor areas within the prostate while reducing radiation to healthy tissue. It may help patients with early-stage prostate cancer get effective treatment with fewer side effects.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.